Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
small decrease » small increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
small decrease » small increased (Expand Search)
-
2541
-
2542
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2543
-
2544
-
2545
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2546
-
2547
-
2548
-
2549
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2550
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2551
-
2552
-
2553
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2554
-
2555
-
2556
-
2557
-
2558
-
2559
-
2560